Clinical and Laboratory Significance of Defective P2Y12 Pathway Function in Patients with Myeloproliferative Neoplasms: A Pilot Study

Publisher： Karger

E-ISSN： 1421-9662|130|3|181-187

ISSN： 0001-5792

Source： Acta Haematologica, Vol.130, Iss.3, 2013-06, pp. : 181-187

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

JAK1/2 inhibition impairs T cell function in vitro and in patients with myeloproliferative neoplasms

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 6, 2015-06 ,pp. : 824-833

John Wiley & Sons Inc

Access to resources Recommend Favorite

P2Y12 receptors: structure and function

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. S1, 2015-06 ,pp. : S10-S16

John Wiley & Sons Inc

Access to resources Recommend Favorite

JAK2 and MPL Mutations in Myeloproliferative Neoplasms

By  

Acta Haematologica, Vol. 119, Iss. 4, 2008-06 ,pp. : 218-225

Karger

Access to resources Recommend Favorite

Frequency and Molecular Characteristics of Calreticulin Gene (CALR) Mutations in Patients with JAK2-Negative Myeloproliferative Neoplasms

By  

Acta Haematologica, Vol. 133, Iss. 2, 2014-10 ,pp. : 193-198

Karger

Access to resources Recommend Favorite

P2Y12 Receptor Inhibitors in Acute Coronary Syndromes: From the Research Laboratory to the Clinic and Vice Versa

By  

Cardiology, Vol. 127, Iss. 4, 2014-01 ,pp. : 211-219

Karger

Access to resources Recommend Favorite